ALKLH Fundamental Analysis - KLEA HOLDING

Fundamental Rating

Taking everything into account, ALKLH scores 3 out of 10 in our fundamental rating. ALKLH was compared to 58 industry peers in the Health Care Equipment & Supplies industry. ALKLH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALKLH is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALKLH had negative earnings in the past year.

ALKLH had a positive operating cash flow in the past year.

In multiple years ALKLH reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: ALKLH reported negative operating cash flow in multiple years.

1.2 Ratios

ALKLH has a Return On Assets (3.71%) which is comparable to the rest of the industry.

ALKLH's Return On Equity of 5.03% is in line compared to the rest of the industry. ALKLH outperforms 46.55% of its industry peers.

With a Return On Invested Capital value of 4.21%, ALKLH perfoms like the industry average, outperforming 43.10% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	3.71%
ROE	5.03%
ROIC	4.21%

ROA(3y)-2.81%

ROA(5y)-21.14%

ROE(3y)-4.32%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 8.14%, ALKLH perfoms like the industry average, outperforming 58.62% of the companies in the same industry.

ALKLH has a Operating Margin (9.65%) which is comparable to the rest of the industry.

ALKLH's Gross Margin of 95.14% is amongst the best of the industry. ALKLH outperforms 98.28% of its industry peers.

In the last couple of years the Gross Margin of ALKLH has grown nicely.

		Industry Rank	Sector Rank
OM	9.65%
PM (TTM)	8.14%
GM	95.14%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y17.3%

GM growth 5Y22.31%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALKLH is destroying value.

The number of shares outstanding for ALKLH has been increased compared to 1 year ago.

Compared to 5 years ago, ALKLH has more shares outstanding

ALKLH has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 4.38 indicates that ALKLH is not in any danger for bankruptcy at the moment.

ALKLH's Altman-Z score of 4.38 is amongst the best of the industry. ALKLH outperforms 82.76% of its industry peers.

The Debt to FCF ratio of ALKLH is 34.84, which is on the high side as it means it would take ALKLH, 34.84 years of fcf income to pay off all of its debts.

ALKLH has a Debt to FCF ratio of 34.84. This is in the lower half of the industry: ALKLH underperforms 60.34% of its industry peers.

A Debt/Equity ratio of 0.15 indicates that ALKLH is not too dependend on debt financing.

ALKLH's Debt to Equity ratio of 0.15 is fine compared to the rest of the industry. ALKLH outperforms 75.86% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	34.84
Altman-Z	4.38

ROIC/WACC0.55

WACC7.71%

2.3 Liquidity

A Current Ratio of 1.35 indicates that ALKLH should not have too much problems paying its short term obligations.

ALKLH's Current ratio of 1.35 is on the low side compared to the rest of the industry. ALKLH is outperformed by 60.34% of its industry peers.

ALKLH has a Quick Ratio of 1.35. This is a normal value and indicates that ALKLH is financially healthy and should not expect problems in meeting its short term obligations.

The Quick ratio of ALKLH (1.35) is better than 68.97% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.35
Quick Ratio	1.35

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 260.87% over the past year.

ALKLH shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.93%.

Measured over the past years, ALKLH shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.

EPS 1Y (TTM)260.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)25.93%

Revenue growth 3Y34%

Revenue growth 5Y11.01%

Sales Q2Q%28.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue is expected to grow by 24.27% on average over the next years. This is a very strong growth

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year34.18%

Revenue Next 2Y24.27%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Forward Earnings ratio of 23.30, ALKLH is valued on the expensive side.

Based on the Price/Forward Earnings ratio, ALKLH is valued a bit cheaper than 62.07% of the companies in the same industry.

ALKLH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	23.3

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALKLH is valued a bit more expensive than 63.79% of the companies in the same industry.

Based on the Price/Free Cash Flow ratio, ALKLH is valued a bit more expensive than the industry average as 60.34% of the companies are valued more cheaply.

		Industry Rank	Sector Rank
P/FCF	444.59
EV/EBITDA	34.25

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALKLH does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KLEA HOLDING

EPA:ALKLH (9/22/2025, 7:00:00 PM)

0.24

+0.02 (+9.09%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)07-21 2025-07-21

Earnings (Next)N/A N/A

Inst Owners1.29%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap73.80M

Analysts86.67

Price Target0.51 (112.5%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	23.3
P/S	4.28
P/FCF	444.59
P/OCF	79.19
P/B	2.64
P/tB	26.24
EV/EBITDA	34.25

EPS(TTM)0

EYN/A

EPS(NY)0.01

Fwd EY4.29%

FCF(TTM)0

FCFY0.22%

OCF(TTM)0

OCFY1.26%

SpS0.06

BVpS0.09

TBVpS0.01

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	3.71%
ROE	5.03%
ROCE	5.12%
ROIC	4.21%
ROICexc	4.68%
ROICexgc	33.31%
OM	9.65%
PM (TTM)	8.14%
GM	95.14%
FCFM	0.96%

ROA(3y)-2.81%

ROA(5y)-21.14%

ROE(3y)-4.32%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y17.3%

GM growth 5Y22.31%

F-Score6

Asset Turnover0.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	34.84
Debt/EBITDA	1.96
Cap/Depr	189.6%
Cap/Sales	4.44%
Interest Coverage	250
Cash Conversion	45.02%
Profit Quality	11.81%
Current Ratio	1.35
Quick Ratio	1.35
Altman-Z	4.38

F-Score6

WACC7.71%

ROIC/WACC0.55

Cap/Depr(3y)158.1%

Cap/Depr(5y)N/A

Cap/Sales(3y)20.55%

Cap/Sales(5y)13.14%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)260.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)25.93%

Revenue growth 3Y34%

Revenue growth 5Y11.01%

Sales Q2Q%28.36%

Revenue Next Year34.18%

Revenue Next 2Y24.27%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y618.1%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year310%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y111.08%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-16.11%

OCF growth 3YN/A

OCF growth 5YN/A

KLEA HOLDING (ALKLH.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens